ArticlePublic health challenges2023
Achieving COVID-19 herd immunity in Algeria: Current state of vaccination, challenges, and recommendations.
Article in Public health challenges, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Achieving COVID-19 herd immunity in Algeria: Current state of vaccination, challenges, and recommendations.Public health challenges · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The COVID-19 pandemic has presented Algeria with a slew of issues, including major economic consequences. Despite implementing containment measures, the government has been unable to fully restrict the spread of the virus. To reestablish normalcy and resume economic activities, the government must discover a means to cohabit with the virus, which requires achieving herd immunity. The World Health Organization (WHO) had set a target for 70% of the population to be fully vaccinated by the end of July 2022 in order to achieve herd immunity. However, whereas vaccines are the preferred method for achieving herd immunity, Algeria has only managed to vaccinate 30.2% of its population, with only 13.5% being fully vaccinated, falling significantly short of the vaccination targets set by the WHO. This is due to vaccine hesitancy and a lack of effective vaccine distribution technology. To reach herd immunity levels, the government must gain and maintain public trust in vaccinations and improve vaccine delivery to hard-to-reach areas. This paper provides an overview of the current COVID-19 situation in Algeria, progress made, and challenges toward achieving herd immunity, and recommends solutions for policymakers to develop sustainable interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.